Biomarkers for Amyotrophic Lateral Sclerosis and Frontotemporal Dementia Associated With Hexanucleotide Expansion Mutations in C9orf72

Now that genetic testing can identify persons at risk for developing amyotrophic lateral sclerosis (ALS) many decades before symptoms begin, there is a critical need for biomarkers that signal the onset and progression of degeneration. The search for candidate disease biomarkers in patients with mut...

Descripción completa

Detalles Bibliográficos
Autores principales: Floeter, Mary Kay, Gendron, Tania F.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289985/
https://www.ncbi.nlm.nih.gov/pubmed/30568632
http://dx.doi.org/10.3389/fneur.2018.01063

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6289985/
https://www.ncbi.nlm.nih.gov/pubmed/30568632
http://dx.doi.org/10.3389/fneur.2018.01063

Ejemplares similares